Repeated anti-CEA radioimmunotherapy (RIT) with 131I-Labetuzumab after complete resection of colorectal liver metastases - safety, feasibility and long-term efficacy results of a prospective phase-II-study
2016 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Repeated anti-CEA radioimmunotherapy (RIT) with 131I-Labetuzumab after complete resection of colorectal liver metastases - safety, feasibility and long-term efficacy results of a prospective phase-II-study
Homayounfar, K. ; Sahlmann, C.-O. ; Niessner, M. ; Dyczkowski, J.; Conradi, L.-C. ; Braulke, F. & Meller, B. et al. (2016)
Oncology Research and Treatment, 39
Basel: Karger.
Documents & Media
Details
- Authors
- Homayounfar, Kia ; Sahlmann, Carsten-Oliver ; Niessner, Martin ; Dyczkowski, Jerzy; Conradi, Lena-Christin ; Braulke, Friederike ; Meller, Birgit ; Beißbarth, Tim ; Ghadimi, Michael B. ; Meller, J.; Goldenberg, David M.; Liersch, Torsten
- Issue Date
- 2016
- Status
- published
- Publisher
- Karger
- Journal
- Oncology Research and Treatment
- ISSN
- 2296-5262; 2296-5270
- Extent
- 13
